skip to main |
skip to sidebar
'The Food and Drug Administration has approved an ingestible digital senor that can track physical health with the assertion that patients are not taking their medication regularly and need a tracking device inside their body to assist them in their medical care….Proteus Digital Health (PDH) released the Ingestion Event Marker (IEM) which was first approved in Europe.
George Savage, co-founder and chief medical officer at PDH claims that this ushers in a new era of digital medicine that “shifts the paradigm.” The IEM, as small as a grain of sand, can be embedded in a pill, and ingested to monitor the patient and their bodily health. The device will collect measurements such as heart rate, body position and activity.'
Read more...
>>>READ MORE
'Digestible microchips embedded in drugs may soon tell doctors whether a patient is taking their medications as prescribed. These sensors are the first ingestible devices approved by the US Food and Drug Administration (FDA). To some, they signify the beginning of an era in digital medicine.
“About half of all people don’t take medications like they’re supposed to,” says Eric Topol, director of the Scripps Translational Science Institute in La Jolla,California. “This device could be a solution to that problem, so that doctors can know when to rev up a patient’s medication adherence.” Topol is not affiliated with the company that manufactures the device, Proteus Digital Health in Redwood City,California, but he embraces the sensor’s futuristic appeal, saying, “It’s like big brother watching you take your medicine.”'
Read more...
>>>READ MORE
